CHRONIC URTICARIA AND HELICOBACTER PYLORI INFECTION: A DECADE OF FINDINGS
Sveikatos mokslai · 15.05.2026 · 140
DOI: 10.35988/sm-hs.2026.131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sveikatos mokslai, online erschienen am 15.05.2026. Verfasst von Justina Norvalaitienė und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Chronic urticaria (CU) is increasingly affecting people worldwide, significantly reducing their quality of life. In many cases, the pathogenesis of this condition remains unknown (idiopathic), making its diagnosis and treatment an important public health issue. Recent studies have drawn attention to a possible relation between CU and H. pylori infection. This article reviewed data from studies, which analysed prevalence of H. pylori among patients with CU in some parts of Europe, Asia, Africa, and Latin America. The findings revealed that the prevalence of H. pylori infection among CU patients ranged from 27% to 100%. Results varied across analyzed studies, influenced by geographical differences and the variety of diagnostic methods used for H. pylori identification. Moreover, some studies suggested that H. pylori eradication resulted in remission of CU in 72.7 – 80% of cases. These results highlight the importance of H. pylori infection diagnosis and eradication in CU management. However, only a limited number of studies have been conducted in Europe.
Zitieren
APA
Norvalaitienė, J., & Gradauskienė, B. (2026). CHRONIC URTICARIA AND HELICOBACTER PYLORI INFECTION: A DECADE OF FINDINGS. Sveikatos mokslai, 140. https://doi.org/10.35988/sm-hs.2026.131
Vancouver
Norvalaitienė J, Gradauskienė B. CHRONIC URTICARIA AND HELICOBACTER PYLORI INFECTION: A DECADE OF FINDINGS. Sveikatos mokslai. 2026:140. doi:10.35988/sm-hs.2026.131
BibTeX
@article{Norvalaitien2026,
author = {Norvalaitienė, Justina and Gradauskienė, Brigita},
title = {CHRONIC URTICARIA AND HELICOBACTER PYLORI INFECTION: A DECADE OF FINDINGS},
journal = {Sveikatos mokslai},
year = {2026},
pages = {140},
doi = {10.35988/sm-hs.2026.131}
}
EUVIMED